Syphilis Testing Market
Syphilis Testing Market Forecasts to 2032 – Global Analysis By Type (Primary Syphilis, Secondary Syphilis, Congenital Syphilis, Latent Syphilis, and Other Types), Location of Testing, Technology, Distribution Channel, Application, End User, and By Geography
According to Stratistics MRC, the Global Syphilis Testing Market is accounted for $2.49 billion in 2025 and is expected to reach $4.49 billion by 2032 growing at a CAGR of 8.8% during the forecast period. Syphilis testing refers to clinical procedures aimed at identifying infection caused by Treponema pallidum, the bacterium that leads to syphilis. Diagnostic methods typically include blood-based non-treponemal and treponemal tests, which help determine disease stage, verify infection, and track patient response to treatment. This testing is vital for reducing disease spread, protecting maternal and infant health, and managing complications. It is particularly significant for individuals at higher risk or with possible exposure to sexually transmitted infections.
Market Dynamics:
Driver:
Increased routine screening programs
The rising implementation of routine syphilis screening initiatives is significantly boosting market demand. Public health agencies are intensifying efforts to detect infections early, especially among high-risk populations such as pregnant women and individuals with HIV. Technological advancements in rapid point-of-care tests are enabling broader deployment across clinics and outreach settings. Integration with digital health platforms is streamlining patient tracking and follow-up diagnostics. Emerging trends include AI-assisted screening algorithms and mobile-based testing kits that improve accessibility. As governments expand STI surveillance programs, syphilis testing is becoming a core component of preventive healthcare strategies.
Restraint:
Inadequate healthcare infrastructure and access
Many low-income countries face shortages in trained personnel, laboratory capacity, and essential testing supplies. Infrastructure gaps are especially pronounced in antenatal care settings, where early detection of congenital syphilis is critical. The lack of digital connectivity further restricts integration with centralized health systems. While mobile clinics and telemedicine offer partial solutions, scalability remains a challenge. Without sustained investment in healthcare infrastructure, syphilis testing coverage will remain uneven across geographies.
Opportunity:
Integration of multiplex and dual-purpose tests
Dual-purpose assays that detect multiple STIs simultaneously are gaining traction in both clinical and public health settings. These platforms reduce turnaround time, improve cost-efficiency, and enhance patient compliance. Advances in microfluidics and biosensor technologies are enabling compact, multi-analyte devices suitable for decentralized use. Regulatory bodies are increasingly supporting bundled testing protocols to streamline care delivery. As personalized medicine evolves, multiplex syphilis tests are expected to play a pivotal role in integrated sexual health diagnostics.
Threat:
Competition from other STI diagnostics
Tests for HIV, chlamydia, and gonorrhea often dominate procurement budgets and public health priorities. Multi-pathogen panels may dilute focus on syphilis-specific innovations unless bundled strategically. Rapid developments in molecular diagnostics and CRISPR-based detection are shifting attention toward newer technologies. Market fragmentation is also driven by regional preferences for certain test formats or brands.
Covid-19 Impact
The pandemic disrupted routine STI screening programs, leading to delayed diagnoses and reduced testing volumes. Lockdowns and resource reallocation toward Covid-19 diagnostics strained laboratory capacity and supply chains. However, the crisis accelerated adoption of remote testing kits and digital reporting platforms for STIs. Emergency regulatory pathways enabled faster approval of novel syphilis assays, including self-testing formats. Post-pandemic strategies now emphasize resilience, decentralized diagnostics, and integration with pandemic preparedness frameworks.
The congenital syphilis segment is expected to be the largest during the forecast period
The congenital syphilis segment is expected to account for the largest market share during the forecast period, due to its critical public health implications. Rising maternal screening mandates and improved prenatal care protocols are driving demand for early detection tools. Technological advances in rapid treponemal tests are enabling timely intervention during pregnancy. Governments are prioritizing congenital syphilis elimination through targeted funding and surveillance programs. Integration with electronic health records is improving case tracking and follow-up treatment. As awareness grows, congenital syphilis testing is becoming a cornerstone of maternal and neonatal health strategies.
The public health programs segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the public health programs segment is predicted to witness the highest growth rate, driven by expanding STI control initiatives worldwide. National and regional campaigns are scaling up syphilis screening through mobile units, community outreach, and school-based interventions. Adoption of cloud-based data systems is enhancing program monitoring and epidemiological insights. Innovations in low-cost, high-throughput testing platforms are making mass screening more feasible. Partnerships between NGOs, governments, and diagnostic firms are accelerating deployment in high-burden areas. As global health priorities shift toward STI elimination, public health programs will be central to market expansion.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share supported by rising healthcare investments and population-wide screening efforts. Countries like China, India, and Indonesia are scaling up STI diagnostics through national health missions and digital health rollouts. Local manufacturing of test kits is improving affordability and supply chain resilience. Emerging trends include AI-powered diagnostic platforms and mobile testing labs tailored for remote regions. Strategic collaborations between global and regional players are enhancing technology transfer and market penetration.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, fuelled by technological leadership and robust public health infrastructure. The U.S. and Canada are investing heavily in next-gen STI diagnostics, including molecular and AI-enhanced platforms. Regulatory agencies are streamlining approvals for innovative syphilis tests, including home-based and telehealth-compatible formats. Integration with electronic medical records and predictive analytics is improving case management and outbreak response. Reimbursement frameworks are increasingly supportive of routine STI screening, especially in underserved communities.
Key players in the market
Some of the key players profiled in the Syphilis Testing Market include Abbott Laboratories, SD Biosensor, Roche Diagnostics, Trinity Biotech, Siemens Healthineers, MedMira Inc., Thermo Fisher Scientific, Fujirebio, Bio-Rad Laboratories, QuidelOrtho Corporation, Danaher Corporation, bioMérieux, Becton, Dickinson and Company (BD), OraSure Technologies, and Hologic Inc.
Key Developments:
In September 2025, Roche announced that it has entered into a definitive merger agreement to acquire 89bio, Inc. a publicly listed clinical-stage biopharmaceutical company pioneering the development of innovative therapies for the treatment of liver and cardiometabolic diseases. 89bio’s pegozafermin is a FGF21 analog currently in late-stage development for MASH.
In February 2025, Abbott and Shedd Aquarium are announcing one of Shedd’s largest corporate gifts in recent history a $10 million pledge from Abbott and Abbott's philanthropic foundation, Abbott Fund. The investment cements the longstanding partnership between Shedd, Abbott, and Abbott Fund to enrich the cultural, educational and environmental fabric of Chicago and spark passion for protecting the ocean environment.
Types Covered:
• Primary Syphilis
• Secondary Syphilis
• Congenital Syphilis
• Latent Syphilis
• Other Types
Location of Testings Covered:
• Laboratory-Based Testing
• Home-Based Testing
• Point-of-Care Testing
Technologies Covered:
• Immunoassay
• Molecular Diagnostics
• Multiplex Platforms
• Other Technologies
Distribution Channels Covered:
• Direct Sales
• Online Pharmacies
• Retail Pharmacies
Applications Covered:
• Hospitals
• Clinics
• Public Health Programs
• Diagnostic Laboratories
• Other Applications
End Users Covered:
• Public Healthcare Facilities
• Private Healthcare Providers
• NGOs and Community Health Centers
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Syphilis Testing Market, By Type
5.1 Introduction
5.2 Primary Syphilis
5.3 Secondary Syphilis
5.4 Congenital Syphilis
5.5 Latent Syphilis
5.6 Other Types
6 Global Syphilis Testing Market, By Location of Testing
6.1 Introduction
6.2 Laboratory-Based Testing
6.3 Home-Based Testing
6.4 Point-of-Care Testing
7 Global Syphilis Testing Market, By Technology
7.1 Introduction
7.2 Immunoassay
7.3 Molecular Diagnostics
7.4 Multiplex Platforms
7.5 Other Technologies
8 Global Syphilis Testing Market, By Distribution Channel
8.1 Introduction
8.2 Direct Sales
8.3 Online Pharmacies
8.4 Retail Pharmacies
9 Global Syphilis Testing Market, By Application
9.1 Introduction
9.2 Hospitals
9.3 Clinics
9.4 Public Health Programs
9.5 Diagnostic Laboratories
9.6 Other Applications
10 Global Syphilis Testing Market, By End User
10.1 Introduction
10.2 Public Healthcare Facilities
10.3 Private Healthcare Providers
10.4 NGOs and Community Health Centers
10.5 Other End Users
11 Global Syphilis Testing Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Abbott Laboratories
13.2 SD Biosensor
13.3 Roche Diagnostics
13.4 Trinity Biotech
13.5 Siemens Healthineers
13.6 MedMira Inc.
13.7 Thermo Fisher Scientific
13.8 Fujirebio
13.9 Bio-Rad Laboratories
13.10 QuidelOrtho Corporation
13.11 Danaher Corporation
13.12 bioMérieux
13.13 Becton, Dickinson and Company (BD)
13.14 OraSure Technologies
13.15 Hologic Inc.
List of Tables
1 Global Syphilis Testing Market Outlook, By Region (2024-2032) ($MN)
2 Global Syphilis Testing Market Outlook, By Type (2024-2032) ($MN)
3 Global Syphilis Testing Market Outlook, By Primary Syphilis (2024-2032) ($MN)
4 Global Syphilis Testing Market Outlook, By Secondary Syphilis (2024-2032) ($MN)
5 Global Syphilis Testing Market Outlook, By Congenital Syphilis (2024-2032) ($MN)
6 Global Syphilis Testing Market Outlook, By Latent Syphilis (2024-2032) ($MN)
7 Global Syphilis Testing Market Outlook, By Other Types (2024-2032) ($MN)
8 Global Syphilis Testing Market Outlook, By Location of Testing (2024-2032) ($MN)
9 Global Syphilis Testing Market Outlook, By Laboratory-Based Testing (2024-2032) ($MN)
10 Global Syphilis Testing Market Outlook, By Home-Based Testing (2024-2032) ($MN)
11 Global Syphilis Testing Market Outlook, By Point-of-Care Testing (2024-2032) ($MN)
12 Global Syphilis Testing Market Outlook, By Technology (2024-2032) ($MN)
13 Global Syphilis Testing Market Outlook, By Immunoassay (2024-2032) ($MN)
14 Global Syphilis Testing Market Outlook, By Molecular Diagnostics (2024-2032) ($MN)
15 Global Syphilis Testing Market Outlook, By Multiplex Platforms (2024-2032) ($MN)
16 Global Syphilis Testing Market Outlook, By Other Technologies (2024-2032) ($MN)
17 Global Syphilis Testing Market Outlook, By Distribution Channel (2024-2032) ($MN)
18 Global Syphilis Testing Market Outlook, By Direct Sales (2024-2032) ($MN)
19 Global Syphilis Testing Market Outlook, By Online Pharmacies (2024-2032) ($MN)
20 Global Syphilis Testing Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
21 Global Syphilis Testing Market Outlook, By Application (2024-2032) ($MN)
22 Global Syphilis Testing Market Outlook, By Hospitals (2024-2032) ($MN)
23 Global Syphilis Testing Market Outlook, By Clinics (2024-2032) ($MN)
24 Global Syphilis Testing Market Outlook, By Public Health Programs (2024-2032) ($MN)
25 Global Syphilis Testing Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
26 Global Syphilis Testing Market Outlook, By Other Applications (2024-2032) ($MN)
27 Global Syphilis Testing Market Outlook, By End User (2024-2032) ($MN)
28 Global Syphilis Testing Market Outlook, By Public Healthcare Facilities (2024-2032) ($MN)
29 Global Syphilis Testing Market Outlook, By Private Healthcare Providers (2024-2032) ($MN)
30 Global Syphilis Testing Market Outlook, By NGOs and Community Health Centers (2024-2032) ($MN)
31 Global Syphilis Testing Market Outlook, By Other End Users (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
